Clinical Trial Update: A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating LB1148 for return of gastrointestinal function after bowel resection and prevention of postoperative adhesions has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ileus
• Postoperative Adhesions

Drugs mentioned

• LB1148 (LB1148)

Snippet

Sponsor: Palisade Bio | Conditions: Ileus, Post-Operative Adhesions | Phase 2 | Status: COMPLETED | Results posted: 2024-06-21